CAS: 1190217-35-6
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | ASP7663 REF: AN-AG01E011CAS: 1190217-35-6 | ≥98%(HPLC) | 110,00 €~1.231,00 € | Jue 02 May 24 |
 | ASP7663 REF: TM-T8410CAS: 1190217-35-6 | 98.11% | 47,00 €~531,00 € | Jue 09 May 24 |
 | ASP 7663 REF: 3D-FA141821CAS: 1190217-35-6 | Min. 95% | A consultar | Jue 13 Jun 24 |
Ref: AN-AG01E011
| 5mg | 196,00 € | |
| 10mg | 292,00 € | |
| 25mg | 536,00 € | |
| 50mg | 848,00 € | |
| 100mg | 1.231,00 € |
Entrega estimada en Estados Unidos, el Jueves 2 de Mayo de 2024
ASP7663
CAS:1190217-35-6
ASP7663 is a TRPA1 Receptor Agonist and exhibiting an abdominal analgesic effect in vivo.
Fórmula:
C14H14FNO3
Pureza:
98.11%
Forma y color:
Solid
Peso molecular:
263.26
Ref: TM-T8410
| 1mg | 47,00 € | |
| 2mg | 62,00 € | |
| 5mg | 92,00 € | |
| 10mg | 129,00 € | |
| 25mg | 230,00 € | |
| 50mg | 365,00 € | |
| 100mg | 531,00 € | |
| 1ml*10 (DMSO) | 94,00 € |
Entrega estimada en Estados Unidos, el Jueves 9 de Mayo de 2024
ASP 7663
CAS:1190217-35-6
ASP 7663 is a new drug that has been developed for the treatment of chronic …
Fórmula:
C14H14FNO3
Pureza:
Min. 95%
Peso molecular:
263.26 g/mol
Ref: 3D-FA141821
| 2mg | A consultar | |
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar |
Entrega estimada en Estados Unidos, el Jueves 13 de Junio de 2024
